Last reviewed · How we verify
NCT03202290: BANCO
BANCO Study: Behavioral Addictions and Related NeuroCOgnitive Aspects: A Monocentric, Prospective, Controlled, Open-label Study of a Sample of Patients With Gambling Disorder
NA trial testing Cognitive and clinical assessment in Gambling Disorder in 50 participants. Completed in 8 January 2026.
8 January 2026
Quick facts
| Lead sponsor | Nantes University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 50 |
| Start date | 24 August 2018 |
| Primary completion | 8 January 2026 |
| Estimated completion | 8 January 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- Cognitive and clinical assessment
Conditions studied
- Gambling Disorder — all drugs for Gambling Disorder →
Sponsor
Nantes University Hospital
Who can join
18 and older, any sex, with Gambling Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The prevalence of people suffering from gambling disorder is relatively high, and the impact on this disorder the individual and those around him is considerable. The etiopathogenic model of gambling disorder is multifactorial, involving various risk and vulnerability factors, involved in the initiation and maintenance of the disorder. Among these factors, neurocognitive alterations associated with the disorder has recently aroused interest among researchers. In this study, the investigators propose to explore the neurocognitive impairments of patients suffering from gambling disorder compared to a control group, in order to identify alterations that could be the target of cognitive remediation programs. Gambling disorder provides a unique opportunity to study the specific neurocognitive impairments of the addictive process because it is not biased by the neurotoxic effect of substances as it is the case in substance use disorders.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
A Case-Control Study on Behavioral Addictions and Neurocognition: Description of the BANCO and BANCO2 Protocols.
Hurel E, Grall-Bronnec M, Thiabaud E, Saillard A, et al · · 2021 · cited 2× · PMID 34321880 · DOI 10.2147/ndt.s292490 -
10th International Conference on Behavioral Addictions (ICBA 2025) July 7–9, 2025, Nantes, France
· 2025
Verify or expand the search:
- PubMed search for NCT03202290
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cognitive and clinical assessment
Trials testing the same drug.
- NCT03967418 — Behavioral Addictions and Related NeuroCOgnitive Aspects · NA · completed
Other recruiting trials for Gambling Disorder
Currently open trials in the same condition.
- NCT03669315 — Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation · Phase 3 · recruiting
Other Nantes University Hospital trials
Trials by the same sponsor.
- NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
- NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
- NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
- NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
- NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03202290 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
- Last refreshed: 22 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03202290.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing